RoundTable News

RoundTable Healthcare Partners Portfolio Company, Renaissance Pharma, Acquires Confab Laboratories

Acquisition provides Renaissance Pharma with platform in contract pharmaceutical manufacturing

LAKE FOREST, IL, December 21, 2010 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that its portfolio company, Renaissance Pharma Inc. (“Renaissance”), has acquired Confab Laboratories Inc. (“Confab”).  Confab is a leading contract pharmaceutical manufacturer in St. Hubert, located on the south shore of Montreal, Québec, Canada.

“Renaissance is excited by the opportunity to further invest in the continued growth and success of Confab,” said Pierre Fréchette, President and CEO of Renaissance.  “As part of Renaissance, we are committed to supporting Confab’s mandate as a unique, fully-integrated pharmaceutical contract manufacturer.”

“RoundTable and Renaissance are ideal partners for Confab,” said Guy Lamarre, founder and former CEO of Confab.  “Their collective industry experience will be instrumental in building on existing partnerships with current customers and developing strong relationships with new ones.”

Mr. Lamarre will remain active in future development of the business as Vice-Chairman of Renaissance.  Accordingly, Nathalie Brisson has been promoted to the position of President and General Manager of Confab and will assume leadership of the day-to-day business operations along with the other members of the existing management team.

“RoundTable is pleased to be working with Renaissance and Confab on this new venture,” stated James E. Utts, Jr., an Operating Partner at RoundTable and the Chairman of the Board of Renaissance.  “We remain enthusiastic about opportunities in the pharmaceutical market and are excited to move forward in support of the Confab team.”

To finance the acquisition of Confab and further growth opportunities, RoundTable facilitated the successful completion of new senior credit facilities and a private placement of senior subordinated notes.  The senior credit facilities were led by GE Commercial Finance Healthcare Financial Services.  Confab’s senior subordinated notes were acquired by RoundTable Capital Partners II (“Capital Fund II”), RoundTable’s second captive subordinated debt fund.  Capital Fund II is a dedicated subordinated debt fund that makes fixed rate subordinated debt investments alongside the equity investments of RoundTable’s equity funds.

About RoundTable Healthcare Partners
RoundTable Healthcare Partners, Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the healthcare industry.  RoundTable partners with companies that can benefit from its extensive industry relationships and proven operating and transaction expertise.  RoundTable has established a successful track record of working with owner/founders, family companies, management teams, entrepreneurs and corporate partners who share a vision and believe in the value creation potential of its partnership model.  RoundTable currently manages $1.9 billion in capital, including three equity funds totaling $1.5 billion and two subordinated debt funds totaling $400 million.  More information about RoundTable Healthcare Partners can be found at

About Renaissance Pharma
Renaissance Pharma is a Montréal-based pharmaceutical company formed in partnership with RoundTable Healthcare Partners and Pierre Fréchette, the former CEO of Sabex, a previous RoundTable portfolio company.  More information about Renaissance can be found

About Confab Laboratories
Founded in 1979, Confab Laboratories Inc. Is a leading FDA approved contract manufacturer to the pharmaceutical industry offering turnkey solutions for manufacturing and packaging clinical and commercial solid, liquid, and semi-solid products.  Confab is located in Saint-Hubert, Quebec.  More information about Confab can be found at

News Release:
272 E. Deerpath Road, Suite 350
Lake Forest, IL 60045
Ph: 847/739-3200; Fax: 847/482-9215
Media Contact:  Betty Rasbid, 847/739-3200